IGSC
The International Gene Synthesis Consortium, an industry self-regulatory body that establishes and promotes customer and sequence screening protocols aimed at preventing synthetic DNA from being used for biosecurity threats.
Timeline (last 90 days)
The International Gene Synthesis Consortium (IGSC) customer and sequence screening protocol requires member companies to perform automated alignment on sequences before accepting synthetic DNA orders, in order to identify whether they involve characteristic fragments of controlled pathogens.
The coverage of the IGSC screening protocol is limited, and non-member companies, academic laboratories, and overseas synthesizers are not bound by it.
Major global DNA synthesis service providers such as Twist Bioscience, IDT, and GenScript all follow screening protocols established by the International Gene Synthesis Consortium (IGSC), comparing sequences against databases of known dangerous pathogen genomes.
All Facts (3)
The International Gene Synthesis Consortium (IGSC) customer and sequence screening protocol requires member companies to perform automated alignment on sequences before accepting synthetic DNA orders, in order to identify whether they involve characteristic fragments of controlled pathogens.
50%UnverifiedThe coverage of the IGSC screening protocol is limited, and non-member companies, academic laboratories, and overseas synthesizers are not bound by it.
50%UnverifiedMajor global DNA synthesis service providers such as Twist Bioscience, IDT, and GenScript all follow screening protocols established by the International Gene Synthesis Consortium (IGSC), comparing sequences against databases of known dangerous pathogen genomes.
50%